Newsroom

Portrait
News
The Helmholtz Centre for Infection Research (HZI) has appointed PD Dr Fabian Leendertz as founding director of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 May 2021. At the same time, he accepted his appointment to a W3 professorship for One Health at the University of Greifswald and is expected to become a university professor on 1 August 2021. As another site of the HZI, the HIOH will in future cooperate closely with the University of Greifswald, Greifswald University Hospital and the Friedrich Loeffler Institute. One Health involves interdisciplinary research at the interface of human health, animal health and the environment.
16.06.2021
Vero6-Zellen infiziert mit SARS-CoV-2
News
How can we apply the knowledge we have gained so far to better overcome the current crisis and prevent another pandemic in future? Helmholtz aims to find answers to these questions with two new, interdisciplinary collaborative projects. In addition to the holistic approach, the focus is also on quickly implementing the results into practice.
20.05.2021
News
Am I infected with SARS-CoV-2? Is it one of the dangerous variants? Being able to answer these and more questions with a single efficient diagnostic test can be decisive for gauging the spread of disease and selecting the right therapy. In a study published today in the journal "Science", researchers from Würzburg at the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius Maximilians University (JMU), tackle this challenge with a new CRISPR discovery they translated into a diagnostic platform called LEOPARD.
27.04.2021
Scanning electron microscope image of Mycobacterium tuberculosis.
Interview
On the occasion of World Tuberculosis Day, Jennifer Herrmann, scientist in the department Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), talks about the epidemiology of the disease and her current research into new active substances against the causative agent of tuberculosis.
23.04.2021
Illustration
News
After exposure to a virus through infection or vaccination, the body activates a number of cells and mechanisms that can provide targeted defense against the pathogen. For the global containment of the SARS-CoV-2 pandemic, the question of how long this protection lasts is an important factor. Prof Carlos Guzmán, vaccine researcher at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, summarizes what is known about long-term immunity to SARS-CoV-2 and what difference it makes whether immunity is acquired through vaccination or infection.
08.04.2021
menschlichen Lungengewebsschnitten
News
In May 2020, the international consortium iCAIR® started a research project aimed at developing therapeutics against SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI), which joined forces with the consortium's core team last year, is also closely involved in this project. The HZI researchers under the leadership of Prof. Ulrich Kalinke have expanded the iCAIR® outstanding talent pool: they boast a successful track record in antiviral drug research, in particular against human pathogenic RNA viruses, and have compound libraries as well as test models and primary virus isolates. In addition, a team from Fraunhofer ITMP led by Prof. Carsten Claussen and Dr. Ole Pless is on board as a temporary project partner. The iCAIR® research team already can report promising results, which were presented by iCAIR® coordinator Prof. Armin Braun and others at Fraunhofer ITEM's virtual workshop "Models of Lung Disease" in January.
08.04.2021

HZI in the media

... Helmholtz-Zentrum für Infektionsforschung

 

02.09.2025 12:36

 

DLR Projektträger

 

02.10.2025 07:49 ...

17.04.2026
|
Informations Dienst Wissenschaft

Wissenschaftler des Max-Delbrück-Centrums und des Helmholtz-Zentrums für Infektionsforschung haben eine umfassende Protein-Karte von

17.04.2026
|
IT Boltwise

In January 2023, researchers at the Helmholtz Institute for One Health in Germany noticed that an infant monkey known as a sooty mangabey

15.04.2026
|
New Atlas

at the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Braunschweig Helmholtz Center for Infection Research (HZI)

14.04.2026
|
Phys.org

... der Infektion und Nozizeption“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig. Nozizeption ist der Fachbegriff ...

14.04.2026
|
Verband Deutscher Biologen e.V.

... recht nicht bei Fabian Leendertz, der in Greifswald das „Helmholtz-Institut für One Health“ leitet. Im ...

14.04.2026
|
FAZ.NET

... sich auch das Helmholtz-Institut für Pharmazeutische Forschung Saarland ( HIPS ), das Helmholtz-Zentrum für Infektionsforschung ( HZI ) ...

09.04.2026
|
Deutsches Ärzteblatt

... ÖAW in Wien und nun Gruppenleiter am Helmholtz Zentrum für Infektionsforschung in Braunschweig, forscht an ...

08.04.2026
|
DerStandard.de

... group within the Microstar Program at the Helmholtz Centre for Infection Research (HZI) and a ...

31.03.2026
|
Informations Dienst Wissenschaft

Register now for the HZI-Newsletter